ArticleFrontiers in cardiovascular medicine2025
Micro-coil embolization for transcatheter septal ablation in a hypertrophic obstructive cardiomyopathy patient and an unusual coronary anatomy: a case report.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- 2026 Expert Consensus Recommendations on Hypertrophic Cardiomyopathy: A Report of the Task Force of the Taiwan Society of Cardiology.Acta Cardiologica Sinica · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Transcatheter septal ablation is a minimally invasive therapeutic method for treating symptomatic obstructive hypertrophic cardiomyopathy (HCM). The procedure is an alternative to septal myectomy, and it can be achieved using different modalities. Coronary artery congenital anomalies can coexist with HCM and can add complexity to its treatment. Case summary: A 65-year-old female presented with angina, reduced exercise tolerance, palpitations, and dizziness. Echocardiography showed eccentric left ventricular hypertrophy with basal septal thickness of 20 mm and left ventricular outflow tract (LVOT) obstruction with maximum gradient of 209 mmHg. Cardiopulmonary exercise stress test showed a decreased oxygen uptake (VO2) of 13.7 ml/min/m2. Medical therapy titrated to maximum tolerated doses failed and septal reduction therapy was indicated. Prior to alcohol septal ablation (ASA), coronary angiography revealed a rare coronary artery anomaly, a single coronary artery originating from the right coronary sinus and the procedure was unsuccessful due to kinking of the over-the-wire (OTW) balloon, caused by the acute take-off angle of the septal branch. The second attempt was done using a microcatheter that was advanced to the septal branch over a hydrophilic coronary guidewire and embolization was done with two micro-coils 2mm × 2 cm. Procedural echocardiography revealed basal septal akinesia and reduced LVOT velocity from 7.24 m/s to 1.5 m/s. After six months, the patient reported a decreased frequency of chest pain and improved exercise tolerance. Echocardiography revealed the septal thickness of 15 mm, with an LVOT gradient of 24 mmHg. Follow-up CT coronary angiography confirmed a "single" coronary artery type R-III, with separate origins of LAD and Cx from the proximal RCA. Part of LAD went through the interventricular septum, forming a myocardial bridge, classified as a potentially "malignant" S subtype. Conclusion: Micro-coil embolization is a feasible alternative treatment to alcohol septal ablation in patients with obstructive HCM and anomalous origin and the course of coronary arteries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.